These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 28102015

  • 1. Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2:ERG.
    Graff RE, Judson G, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A.
    Prostate; 2017 May; 77(6):647-653. PubMed ID: 28102015
    [Abstract] [Full Text] [Related]

  • 2. Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression.
    Graff RE, Meisner A, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A.
    Br J Cancer; 2016 Apr 12; 114(8):939-44. PubMed ID: 26986253
    [Abstract] [Full Text] [Related]

  • 3. A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG.
    Pernar CH, Ebot EM, Pettersson A, Graff RE, Giunchi F, Ahearn TU, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Stopsack KH, Gazeeva E, Lis RT, Parmigiani G, Rimm EB, Finn SP, Giovannucci EL, Fiorentino M, Mucci LA.
    Eur Urol; 2019 Jul 12; 76(1):33-40. PubMed ID: 30301696
    [Abstract] [Full Text] [Related]

  • 4. Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer.
    Cornu JN, Cancel-Tassin G, Egrot C, Gaffory C, Haab F, Cussenot O.
    Prostate; 2013 Feb 15; 73(3):242-9. PubMed ID: 22821767
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.
    Laxman B, Tomlins SA, Mehra R, Morris DS, Wang L, Helgeson BE, Shah RB, Rubin MA, Wei JT, Chinnaiyan AM.
    Neoplasia; 2006 Oct 15; 8(10):885-8. PubMed ID: 17059688
    [Abstract] [Full Text] [Related]

  • 7. Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status.
    Egbers L, Luedeke M, Rinckleb A, Kolb S, Wright JL, Maier C, Neuhouser ML, Stanford JL.
    Am J Epidemiol; 2015 May 01; 181(9):706-13. PubMed ID: 25852077
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ.
    Cancer Res; 1999 Mar 15; 59(6):1225-30. PubMed ID: 10096552
    [Abstract] [Full Text] [Related]

  • 10. Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer.
    Graff RE, Ahearn TU, Pettersson A, Ebot EM, Gerke T, Penney KL, Wilson KM, Markt SC, Pernar CH, Gonzalez-Feliciano AG, Song M, Lis RT, Schmidt DR, Vander Heiden MG, Fiorentino M, Giovannucci EL, Loda M, Mucci LA.
    Cancer Epidemiol Biomarkers Prev; 2018 Feb 15; 27(2):193-200. PubMed ID: 29167279
    [Abstract] [Full Text] [Related]

  • 11. Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression.
    Graff RE, Pettersson A, Lis RT, Ahearn TU, Markt SC, Wilson KM, Rider JR, Fiorentino M, Finn S, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Mucci LA.
    Am J Clin Nutr; 2016 Mar 15; 103(3):851-60. PubMed ID: 26817504
    [Abstract] [Full Text] [Related]

  • 12. Retention of Interstitial Genes between TMPRSS2 and ERG Is Associated with Low-Risk Prostate Cancer.
    Murphy SJ, Kosari F, Karnes RJ, Nasir A, Johnson SH, Gaitatzes AG, Smadbeck JB, Rangel LJ, Vasmatzis G, Cheville JC.
    Cancer Res; 2017 Nov 15; 77(22):6157-6167. PubMed ID: 29127096
    [Abstract] [Full Text] [Related]

  • 13. TMPRSS2:ERG gene aberrations may provide insight into pT stage in prostate cancer.
    Krstanoski Z, Vokac NK, Zagorac A, Pospihalj B, Munda M, Dzeroski S, Golouh R.
    BMC Urol; 2016 Jul 04; 16(1):35. PubMed ID: 27377958
    [Abstract] [Full Text] [Related]

  • 14. [Diagnostic value of estimation of ERG expression in prostate adenocarcinoma and high-grade prostatic intraepithelial neoplasia].
    Allina DO, Kekeeva TV, Moskvina LV, Shikeeva AA, Andreeva YY, Zavalishina LE, Frank GA.
    Arkh Patol; 2015 Jul 04; 77(5):36-42. PubMed ID: 26978019
    [Abstract] [Full Text] [Related]

  • 15. Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers.
    Dhani NC, Emmenegger U, Adams L, Jongstra J, Tannock IF, Sridhar SS, Knox JJ, Day JR, Groskopf J, Joshua AM.
    BJU Int; 2012 Sep 04; 110(6):840-5. PubMed ID: 22313860
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancers.
    Fleischmann A, Saramäki OR, Zlobec I, Rotzer D, Genitsch V, Seiler R, Visakorpi T, Thalmann GN.
    Prostate; 2014 Dec 04; 74(16):1647-54. PubMed ID: 25252136
    [Abstract] [Full Text] [Related]

  • 19. Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes.
    Penney KL, Pettersson A, Shui IM, Graff RE, Kraft P, Lis RT, Sesso HD, Loda M, Mucci LA.
    Cancer Epidemiol Biomarkers Prev; 2016 May 04; 25(5):745-9. PubMed ID: 26941365
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.